Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin.
about
Glycation of LDL by methylglyoxal increases arterial atherogenicity: a possible contributor to increased risk of cardiovascular disease in diabetesReduced apolipoprotein glycosylation in patients with the metabolic syndromeArginine-directed glycation and decreased HDL plasma concentration and functionalityAn effective and rapid determination by MALDI/TOF/TOF of methionine sulphoxide content of ApoA-I in type 2 diabetic patients.Absence of an effect of vitamin E on protein and lipid radical formation during lipoperoxidation of LDL by lipoxygenase.Pathophysiology of diabetic dyslipidaemia: where are we?The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.Papaverine increases human serum albumin glycation.Levels of Apolipoprotein A1, B100 and Lipoprotein (a) in Controlled and Uncontrolled Diabetic Patients and in Non-Diabetic Healthy People.Glycation research in amino acids: a place to call home.Protein damage in diabetes and uremia--identifying hotspots of proteome damage where minimal modification is amplified to marked pathophysiological effect.Current therapeutic interventions in the glycation pathway: evidence from clinical studies.Chemical and biological methods to detect post-translational modifications of arginine.Non-enzymatic glycation and glycoxidation protein products in foods and diseases: an interconnected, complex scenario fully open to innovative proteomic studies.Redox regulation of protein damage in plasma.Dicarbonyl proteome and genome damage in metabolic and vascular disease.Methylglyoxal in diabetes: link to treatment, glycaemic control and biomarkers of complications.Carbonyl stress and schizophrenia.The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases.Oxidative stress and DNA methylation regulation in the metabolic syndrome.Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.Advanced glycation of high-density lipoprotein and the functionality of aldosterone release in type 2 diabetes.Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions.Mass spectrometric determination of early and advanced glycation in biology.Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises.Reactive oxygen species: key regulators in vascular health and diseases.Inhibition of nonenzymatic protein glycation by pomegranate and other fruit juices.(R)-α-Lipoic acid inhibits fructose-induced myoglobin fructation and the formation of advanced glycation end products (AGEs) in vitro.Oxygen restriction as challenge test reveals early high-fat-diet-induced changes in glucose and lipid metabolism.Metformin restores the correlation between serum-oxidized LDL and leptin levels in type 2 diabetic patients.Acute glutathione depletion induces hepatic methylglyoxal accumulation by impairing its detoxification to D-lactate.
P2860
Q24608214-2388D54A-C1F1-46F4-A072-79BAE9DE1EAFQ28541818-D306D18E-3122-43D7-8B50-E37EE46C1701Q34284245-99349157-99F7-4F44-AD3A-06932C8925ABQ34543361-846CBFAA-22FF-4996-8A34-BCE7693E04E7Q34616416-2C56759E-0F08-4EF1-A167-9A9EA50246D6Q35350326-2C36580E-B27A-44A0-8C61-C824D723072FQ36625195-EEB4652D-3C9B-49EC-B809-A52EE92F102CQ36775168-3D3EBA57-5E81-480D-8AB0-78D4E27B8F1CQ37091275-DCEA5578-9295-4D7C-AEB6-0CD1C11B1B1FQ37582964-4F8D79B1-D0E7-4726-837C-4BC265B0AD5AQ37734181-5D3B64B3-2ED4-4318-B90F-B1D3FB5AF8DAQ37803550-94954A09-3E55-4B95-B71D-854B98D176B4Q37812619-A993974E-6440-4F7C-8690-22138A6E087CQ38070906-B88D9128-9AF0-4E9F-B974-C806CC6C01F1Q38098140-E113F6EF-D826-4448-836D-2107C1D3EF78Q38151611-C3697A25-1F90-4B1A-B7EA-8C0F7E23167BQ38195611-7EB623EB-ED80-4BFD-A9DC-BF8D1CED7408Q38197339-8B53C60A-5BBE-419F-9E72-F94B567FD948Q38197344-FE06C727-1066-42AD-B950-D104EF477CEBQ38226316-E302C038-1CF8-4908-A461-DC1DA3DA31C9Q38394355-B6E1880D-5DCA-4277-82B9-F32EF02227ADQ38459861-55C0B895-9A5D-45C4-9AD6-F25CA4B4EDE9Q38620860-F4AFAF9C-F6FD-4EC3-B7B2-30D60D189E08Q38741489-09D9C306-DC58-4C16-9CAB-302F5B8142F2Q38837915-9E6CBFA7-1397-40A8-AFFD-DBDD7D8E35EAQ38839770-C5BD0ECF-FD55-42CC-A6AE-E9B0FB14C6CAQ38956425-AF0BC06A-B022-473A-9EE5-B643BEA0629EQ39254617-319BBC84-E4E3-4875-AF91-C8E67FA41266Q40981408-68A4B1B6-ACF0-4AEF-9100-F18381C3F834Q48241756-65F2C5B0-43F3-4D38-BBCF-D33D0146B2FDQ51319926-926B9835-8951-49AB-8D30-F64C796A28CCQ51366721-736D7F94-D551-4EC8-8062-7298C193BB8BQ53326322-9E12E9E8-F65C-41D6-95BA-EBAA4DE730FA
P2860
Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Increased glycation and oxidat ...... betes and effect of metformin.
@ast
Increased glycation and oxidat ...... betes and effect of metformin.
@en
type
label
Increased glycation and oxidat ...... betes and effect of metformin.
@ast
Increased glycation and oxidat ...... betes and effect of metformin.
@en
prefLabel
Increased glycation and oxidat ...... betes and effect of metformin.
@ast
Increased glycation and oxidat ...... betes and effect of metformin.
@en
P2093
P2860
P356
P1433
P1476
Increased glycation and oxidat ...... betes and effect of metformin.
@en
P2093
Charles W Bodmer
Daniel Zehnder
Madhu Varma Chittari
Naila Rabbani
P2860
P304
P356
10.2337/DB09-1455
P407
P577
2010-01-12T00:00:00Z